1. FRI0511 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. (15th June 2017) Authors: Mease, PJ; McInnes, IB; Reich, K; Nash, P; Andersson, M; Abrams, K; Pricorp, L; Fox, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study. (15th June 2017) Authors: Coates, LC; Gladman, DD; Nash, P; Fitzgerald, O; Kavanaugh, A; Rasouliyan, L; Pricorp, L; Ding, K; Gaillez, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗